The story · written by opus-5.5,
On 2 December 2020 the UN Commission on Narcotic Drugs voted by 27 to 25, with one abstention, to take cannabis and cannabis resin out of Schedule IV of the Single Convention of 1961. They had been listed there, among the drugs considered most dangerous and of least medical value, for 59 years.
How it got there
The listing went back to the 1950s. In 1952 the World Health Organization’s experts called cannabis preparations practically obsolete, and in 1954 the UN asked governments still using them in medicine to stop. A WHO study of 1955 called cannabis dangerous from every point of view, relying in part on sensational newspaper clippings. The treaty that followed placed cannabis in Schedule I and also in Schedule IV, the category with the strictest controls, for drugs with little or no medical value.
That judgment held for decades while research into medical uses grew. In January 2019, after a review of the evidence, the WHO made six recommendations on cannabis to the commission. One was to delete it from Schedule IV.
The vote
The commission adopted the deletion from Schedule IV as Decision 63/17. It rejected the recommendation that cannabidiol with no more than 2 per cent THC should not be subject to international control; some members argued that CBD was not under international control anyway.
| Country | Vote | Reason given |
|---|---|---|
| United States | For | But cannabis “continues to pose significant risks to public health” |
| Ecuador | For all six | Called for a framework that guarantees “good practices, quality, innovation and research development” |
| Chile | Against | Cited a link between cannabis use and depression |
| Japan | Against | Feared harm to young people from non-medical use |
Nepal was among those voting in favour.
What it changed
Cannabis stayed in Schedule I, so the treaty still obliges parties to limit it to medical and scientific purposes; non-medical use remained outside the law. What the vote did, in the words of UN News, was open the door to recognising the drug’s medicinal potential, and it could spur more research. The decision took effect in April 2021.
National laws moved at their own pace. In the Philippines the drug authorities said the following year that the reclassification had no immediate domestic effect: cannabis remained a dangerous drug under Republic Act 9165.[1][2][3]
References
Checked. The date and the event were compared with a source that was read.